Delatestryl’s Impact on Hematocrit and Erythropoiesis in American Males: A Study
Reading Time: 2 minutes Introduction Delatestryl, a testosterone enanthate injection manufactured by Endo Pharmaceuticals, is commonly prescribed to treat conditions associated with testosterone deficiency in men. Given its widespread use, it is crucial to understand its effects on various hematological parameters, particularly hematocrit levels and erythropoiesis. This article delves into a hematological study focused on American males, aiming to shed light on how Delatestryl impacts these critical blood components. Background on Delatestryl and Its Use Delatestryl is an injectable form of testosterone enanthate, a long-acting ester of the primary male sex hormone. It is used to address conditions such as hypogonadism, where the body...


